Your account is not claimed yet. You can sign up with ORCID to claim your account.

Junling Zhuang

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Acute Myeloid Leukemia

Ejection Fraction

Multiple Myeloma

Prognostic Factors

Top Venues

Annals of hematology

Thoracic cancer

American journal of hematology

Chronic diseases and translational medicine

Peking Union Medical College Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Peking Union Medical College Hospital

China

Vice Director :: Hematology

Publications

Xianghong Jin, Xianyong Jiang, Wei Wang, Shuangjiao Liu, Bing Han, Jianhua Han, Junling Zhuang
Pure red cell aplasia and minimal residual disease conversion associated with immune reconstitution in a patient with high-risk multiple myeloma. Chronic diseases and translational medicine 9 (4) (2023)
Yi Zhang, Hu Zhou, Zhongxing Jiang, Dengshu Wu, Junling Zhuang, Wei Li, Qian Jiang, Xiuli Wang, Jinwen Huang, Huan-Ling Zhu, Linhua Yang, Xin Du, Fei Li, Ruixiang Xia, Feng Zhang, Jian-da Hu, Yan Li, Han Yan, Jing Liu, Chenghao Jin, Kai Sun, Zeping Zhou, Liqing Wu, Wenjuan Yu, Jie Jin
Safety and efficacy of jaktinib in the treatment of Janus kinase inhibitor-naïve patients with myelofibrosis: Results of a phase II trial. American journal of hematology 97 (12) (2022)
Yuanyuan Jin, Xiaochen Yu, Jianhua Du, Hui Li, Wenjiao Tang, Congwei Jia, Yunyan Zan, Miao Chen, Yanbin Zhang, Minhong Yu, Weiqi Rong, Daobin Zhou, Junling Zhuang
The combination of C-Myc rearrangement and 1q21 gain is associated with poor prognosis in multiple myeloma. Annals of hematology 100 (5) (2021)
Junling Zhuang, Jianhua Du, Xiaoxiao Guo, Jiaxin Zhou, Lian Duan, Wei Qiu, Xiao-Yan Si, Li Zhang, Yue Li, Xiaowei Liu, Hanping Wang, Daobin Zhou, Li Zhang
Clinical diagnosis and treatment recommendations for immune checkpoint inhibitor-related hematological adverse events. Thoracic cancer 11 (3) (2020)